Results 81 to 90 of about 24,190 (185)
Objective. In this study, we evaluated the utility of 16-slice MDCT (multidetector computed tomography) to assess stent patency after coronary artery stenting. Materials and Methods. Retrospective ECG-gated CT-angiography using 16-slice MDCT was
Irmak Durur-Subasi +3 more
doaj
Aim. To study the relationship between plasma levels of lipoprotein(a) (Lp(a)), vascular endothelial growth factor (VEGF), transforming growth factor β (TGF-β), and the occurrence of stent restenosis after percutaneous coronary intervention (PCI) in ...
M. А. Meshkova +2 more
doaj +1 more source
Percutaneous coronary intervention (PCI) is a common minimally-invasive procedure for treating coronary artery stenosis. However, 10% of patients with non-complex lesions experience restenosis within five years of initial PCI.
Travis C. Singh +5 more
doaj +1 more source
Update on stents: Recent studies on the TAXUS® stent system in small vessels
Shuzou Tanimoto, Joost Daemen, Patrick W SerruysThoraxcenter, Erasmus Medical Center, Rotterdam, The NetherlandsAbstract: Small vessel size (<3 mm) has been identified as an independent predictive factor of restenosis after percutaneous coronary ...
Shuzou Tanimoto +2 more
doaj
Lyudmila Pivina,1 Gulnara Batenova,1 Nazarbek Omarov,1 Diana Ygiyeva,1 Assylzhan Messova,1 Galiya Alibayeva,2 Ulzhan Jamedinova,1 Ruslan Kurumbayev,1 Maksim Pivin3 1Department of Emergency Medicine, Semey Medical University, Semey, Abay Region ...
Pivina L +8 more
doaj
Fibroblast Activation Targeted Imaging Identifies Coronary Restenosis. [PDF]
Xi XY, Yang S, Tu B, Zhao L, Yang MF.
europepmc +1 more source
Sirolimus <i>vs</i> paclitaxel-coated balloons in in-stent coronary restenosis: A meta-analysis. [PDF]
Mandal D +13 more
europepmc +1 more source
Identification of completed coronary stent healing by optical coherence tomography - validation study with histopathology in porcine model of coronary restenosis. [PDF]
Pruski M +9 more
europepmc +1 more source
Recurrent Intra-Stent Coronary Restenosis in a Carrier of Non-Disease-Specific Antinuclear Antibodies. [PDF]
Tomberli B +5 more
europepmc +1 more source

